These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18356253)

  • 1. Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease.
    Reuter I; Tai YF; Pavese N; Chaudhuri KR; Mason S; Polkey CE; Clough C; Brooks DJ; Barker RA; Piccini P
    J Neurol Neurosurg Psychiatry; 2008 Aug; 79(8):948-51. PubMed ID: 18356253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease.
    Barker RA; Mason SL; Harrower TP; Swain RA; Ho AK; Sahakian BJ; Mathur R; Elneil S; Thornton S; Hurrelbrink C; Armstrong RJ; Tyers P; Smith E; Carpenter A; Piccini P; Tai YF; Brooks DJ; Pavese N; Watts C; Pickard JD; Rosser AE; Dunnett SB;
    J Neurol Neurosurg Psychiatry; 2013 Jun; 84(6):657-65. PubMed ID: 23345280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological findings on fetal striatal grafts in a Huntington's disease patient early after transplantation.
    Capetian P; Knoth R; Maciaczyk J; Pantazis G; Ditter M; Bokla L; Landwehrmeyer GB; Volk B; Nikkhah G
    Neuroscience; 2009 May; 160(3):661-75. PubMed ID: 19254752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human striatal neuroblasts develop and build a striatal-like structure into the brain of Huntington's disease patients after transplantation.
    Gallina P; Paganini M; Lombardini L; Mascalchi M; Porfirio B; Gadda D; Marini M; Pinzani P; Salvianti F; Crescioli C; Bucciantini S; Mechi C; Sarchielli E; Romoli AM; Bertini E; Urbani S; Bartolozzi B; De Cristofaro MT; Piacentini S; Saccardi R; Pupi A; Vannelli GB; Di Lorenzo N
    Exp Neurol; 2010 Mar; 222(1):30-41. PubMed ID: 20026043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral human fetal striatal transplantation in Huntington's disease.
    Hauser RA; Furtado S; Cimino CR; Delgado H; Eichler S; Schwartz S; Scott D; Nauert GM; Soety E; Sossi V; Holt DA; Sanberg PR; Stoessl AJ; Freeman TB
    Neurology; 2002 Mar; 58(5):687-95. PubMed ID: 11889229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzodiazepine receptor binding in Huntington's disease: [11C]flumazenil uptake measured using positron emission tomography.
    Künig G; Leenders KL; Sanchez-Pernaute R; Antonini A; Vontobel P; Verhagen A; Günther I
    Ann Neurol; 2000 May; 47(5):644-8. PubMed ID: 10805336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475.
    Rosser AE; Barker RA; Harrower T; Watts C; Farrington M; Ho AK; Burnstein RM; Menon DK; Gillard JH; Pickard J; Dunnett SB;
    J Neurol Neurosurg Psychiatry; 2002 Dec; 73(6):678-85. PubMed ID: 12438470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of intrastriatal neurotransplantation for Huntington's disease patients.
    Kopyov OV; Jacques S; Lieberman A; Duma CM; Eagle KS
    Exp Neurol; 1998 Jan; 149(1):97-108. PubMed ID: 9454619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of human striatal anlagen after transplantation in a patient with Huntington's disease.
    Gallina P; Paganini M; Lombardini L; Saccardi R; Marini M; De Cristofaro MT; Pinzani P; Salvianti F; Crescioli C; Di Rita A; Bucciantini S; Mechi C; Sarchielli E; Moretti M; Piacentini S; Gritti G; Bosi A; Sorbi S; Orlandini G; Vannelli GB; Di Lorenzo N
    Exp Neurol; 2008 Sep; 213(1):241-4. PubMed ID: 18601923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal striatal grafting slows motor and cognitive decline of Huntington's disease.
    Paganini M; Biggeri A; Romoli AM; Mechi C; Ghelli E; Berti V; Pradella S; Bucciantini S; Catelan D; Saccardi R; Lombardini L; Mascalchi M; Massacesi L; Porfirio B; Di Lorenzo N; Vannelli GB; Gallina P
    J Neurol Neurosurg Psychiatry; 2014 Sep; 85(9):974-81. PubMed ID: 24347577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Core Assessment Program for Intracerebral Transplantation in Huntington's Disease (CAPIT-HD).
    Quinn N; Brown R; Craufurd D; Goldman S; Hodges J; Kieburtz K; Lindvall O; MacMillan J; Roos R
    Mov Disord; 1996 Mar; 11(2):143-50. PubMed ID: 8684383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease.
    Antonini A; Leenders KL; Spiegel R; Meier D; Vontobel P; Weigell-Weber M; Sanchez-Pernaute R; de Yébenez JG; Boesiger P; Weindl A; Maguire RP
    Brain; 1996 Dec; 119 ( Pt 6)():2085-95. PubMed ID: 9010012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal striatal transplantation in Huntington's disease: time for a pause.
    Albin RL
    J Neurol Neurosurg Psychiatry; 2002 Dec; 73(6):612. PubMed ID: 12438457
    [No Abstract]   [Full Text] [Related]  

  • 14. A primate model of Huntington's disease: functional neural transplantation and CT-guided stereotactic procedures.
    Schumacher JM; Hantraye P; Brownell AL; Riche D; Madras BK; Davenport PD; Maziere M; Elmaleh DR; Brownell GL; Isacson O
    Cell Transplant; 1992; 1(4):313-22. PubMed ID: 1344304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human fetal striatal transplantation in an excitotoxic lesioned model of Huntington's disease.
    Sanberg PR; Borlongan CV; Koutouzis TK; Norgren RB; Cahill DW; Freeman TB
    Ann N Y Acad Sci; 1997 Dec; 831():452-60. PubMed ID: 9616734
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.
    Antonini A; Schwarz J; Oertel WH; Pogarell O; Leenders KL
    Mov Disord; 1997 Jan; 12(1):33-8. PubMed ID: 8990051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human striatum remodelling after neurotransplantation in Huntington's disease.
    Gallina P; Paganini M; Biggeri A; Marini M; Romoli A; Sarchielli E; Berti V; Ghelli E; Guido C; Lombardini L; Mazzanti B; Simonelli P; Peri A; Maggi M; Porfirio B; Di Lorenzo N; Vannelli GB
    Stereotact Funct Neurosurg; 2014; 92(4):211-7. PubMed ID: 25096235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [11C]raclopride-PET studies of the Huntington's disease rate of progression: relevance of the trinucleotide repeat length.
    Antonini A; Leenders KL; Eidelberg D
    Ann Neurol; 1998 Feb; 43(2):253-5. PubMed ID: 9485067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatal allografts in patients with Huntington's disease: impact of diminished astrocytes and vascularization on graft viability.
    Cisbani G; Freeman TB; Soulet D; Saint-Pierre M; Gagnon D; Parent M; Hauser RA; Barker RA; Cicchetti F
    Brain; 2013 Feb; 136(Pt 2):433-43. PubMed ID: 23378216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.
    Antonini A; Vontobel P; Psylla M; Günther I; Maguire PR; Missimer J; Leenders KL
    Arch Neurol; 1995 Dec; 52(12):1183-90. PubMed ID: 7492293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.